CORRECTED-Patheon Thermo Fisher to produce COVID-19 vaccine in Italy -govt source
Corrects spelling of company in headline and throughout text to Patheon Thermo Fisher, not Patheon Thermo Fischer
ROME, March 15 (Reuters) - Patheon Thermo Fisher, part of U.S.-listed Thermo Fisher Scientific TMO.N, is ready to launch mass production of a COVID-19 vaccine in Italy, an Italian government source told Reuters.
The source added that Patheon had signed a letter of intent to produce vaccines in Italy, without giving details.
Earlier on Friday, Italy's Prime Minister Mario Draghi said that a company based in the country had signed an agreement with one of the pharmaceutical groups owning the patent for the vaccine to start local production.
Patheon is based outside Milan, Italy's financial capital.
(Reporting by Giuseppe Fonte; writing by Francesca Landini; editing by Jonathan Oatis